Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Shares IssuedShares OutstandingShares Outstanding
Ratios

Greenwich LifeSciences (GLSI) Shares Repurchased (2022)

Greenwich LifeSciences filings provide 1 years of Shares Repurchased readings, the most recent being $2.0 million for Q2 2022.

  • Quarterly Shares Repurchased changed N/A to $2.0 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2022, changed N/A year-over-year, with the annual reading at $7.5 million for FY2022, N/A changed from the prior year.
  • Shares Repurchased hit $2.0 million in Q2 2022 for Greenwich LifeSciences, down from $5.5 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $5.5 million in Q1 2022 and bottomed at $2.0 million in Q2 2022.